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Conventional subthalamic deep brain stimulation for Parkinson’s disease (PD) presumably 
modulates the spatial component of gait. However, temporal dysregulation of gait is one 
of the factors that is tightly associated with freezing of gait (FOG). Temporal locomotor 
integration may be modulated differentially at distinct levels of the basal ganglia. Owing 
to its specific descending brainstem projections, stimulation of the substantia nigra pars 
reticulata (SNr) area might modulate spatial and temporal parameters of gait differentially 
compared to standard subthalamic nucleus (STN) stimulation. Here, we aimed to char-
acterize the differential effect of STN or SNr stimulation on kinematic gait parameters. We 
analyzed biomechanical parameters during unconstrained over ground walking in 12 PD 
patients with subthalamic deep brain stimulation and FOG. Patients performed walking 
in three therapeutic conditions: (i) Off stimulation, (ii) STN stimulation (alone), and (iii) SNr 
stimulation (alone). SNr stimulation was achieved by stimulating the most caudal contact 
of the electrode. We recorded gait using three sensors (each containing a tri-axial accel-
erometer, gyroscope, and magnetometer) attached on both left and right ankle, and 
to the lumbar spine. STN stimulation improved both the spatial features (stride length, 
stride length variability) and the temporal parameters of gait. SNr stimulation improved 
temporal parameters of gait (swing time asymmetry). Correlation analysis suggested 
that patients with more medial localization of the SNr contact associated with a stronger 
regularization of gait. These results suggest that SNr stimulation might support temporal 
regularization of gait integration.
Keywords: Parkinson’s disease, subthalamic nucleus deep brain stimulation, gait, freezing of gait, nigral 
stimulation
inTrODUcTiOn
Standard deep brain stimulation of the subthalamic nucleus (STN-DBS) may improve gait in 
Parkinson’s disease (PD) with interindividual variability (1, 2). STN-DBS was shown to modulate the 
spatial- and spatiotemporal parameters (e.g., step length, step velocity), however, the pure temporal 
parameters (e.g., step time) were less amenable to STN-DBS (3–5) and possibly more dependent on 
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contributions from the mesencephalic locomotor region (MLR) 
along previous findings (6, 7). Taken together, the spatial and 
temporal parameters of gait do not act independently; however, 
there may be weighted contributions to either spatial or temporal 
parameters from different nodes of the wide-spread locomotor 
network. This is critical, as temporal regulation of the gait cycle is 
crucial to PD gait disturbance, in particular to PD patients with 
freezing of gait (FOG). Temporal abnormalities of locomotor 
integration may increase susceptibility to FOG (8). In this sense, 
several temporal parameters of gait, including temporal gait vari-
ability and asymmetry, are deteriorated in PD freezers (9, 10).
Rhythmic stepping behavior can be elicited by stimulation of 
the MLR in cat, with higher stimulation intensities increasing 
the cadence along temporal locomotor integration (11, 12). The 
MLR gives rise to the reticulospinal tract and this tract appears 
to be involved in eliminating asymmetric gait by modulating the 
activity level of different groups of muscles during walking (13). 
In human beings, the MLR was referred to the pedunculopontine 
and cuneiform nuclei in previous work (6, 12, 13). The MLR 
appears to be involved in the temporal modulation of gait in 
human beings as well (6, 7). The MLR appears to be involved 
in the temporal modulation of gait in human as well. In healthy 
subjects, the MLR is active during mental imagery of gait (6). 
Furthermore, increased cadence of stepping in PD patients asso-
ciates with increased firing rates of neurons in the MLR (7). The 
MLR receives GABAergic afferents from the substantia nigra pars 
reticulata (SNr), a major basal ganglia output nucleus (14). In PD, 
the output of the basal ganglia including SNr is increased (15), 
presumably resulting in over-inhibition of the MLR. Accordingly, 
increased inhibitory SNr output is suspected to attenuate MLR 
locomotor output.
High-frequency stimulation likely attenuates over-inhibitory 
output both on the level of STN and SNr (16, 17). There is 
clinical evidence that STN-DBS modulates locomotor integra-
tion and FOG (18, 19). A recent trial observed that adding nigral 
stimulation to the conventional STN-DBS may improve gait in 
PD freezers (20). Efficacy of STN +  SNr on FOG as primary 
clinical outcome measure is under investigation in a multicenter 
randomized controlled trial (clinicaltrials.gov NCT02588144).
Here, we set out to study the effects of mono STN or mono 
SNr stimulation (each applied as single target stimulation) on 
gait kinematics of PD freezers. We conducted this study under 
the primary interest, whether mono STN or mono SNr stimula-
tion would elicit differential effects on locomotion in terms of 
kinematic gait properties. Of note, this pathophysiological 
groundwork here was not designed nor powered to study the 
clinical efficacy of nigral stimulation on FOG. In particular, we 
contrasted the effect of either STN or SNr stimulation as single 
target stimulation on both spatial and temporal kinematic gait 
parameters of unconstrained gait, which would provide insight 
into the underlying pathophysiological and network effects of 
each distinct target within the complex locomotor network. 
Furthermore, we aimed to associate the anatomical position of 
SNr contacts with their potential to modulate gait parameters, 
since—from animal experiments—it was indicated that SNr 
subterritories may differentially modulate distinct parameters 
of locomotor integration. In this sense, the medial part of the 
SNr was suggested to account for the modulation of the cadence 
(21, 22). Instead, stimulation of the lateral part of the SNr presum-
ably led to an increase of axial and limbic muscle tone (21, 23). 
We hypothesize that STN stimulation will modulate the spatial 
parameters by increasing the stride length and reducing the stride 
length variability as compared to Off stimulation. We hypothesize 
that SNr stimulation (owing to its MLR connectivity) regularizes 
the temporal measures of gait as compared to Off stimulation 
by decreasing the variability of the step time and temporal gait 
asymmetry. Furthermore, we hypothesize that the improvement 
in temporal gait variability and asymmetry may associate with a 
more medial localization of the SNr contact.
MaTerials anD MeThODs
subjects
We included 21 patients with idiopathic PD and STN-DBS 
into this study. PD patients were included in the post-operative 
chronic follow-up period, if already pre-existing electrode con-
tacts of the quadripolar lead (electrode model 3389, Medtronic, 
Minneapolis, MN, USA) reached both the STN and the caudal 
border zone of the STN and SNr (20). The pre-operative target-
ing occurred under routine clinical care (not subject to this study 
protocol) and primarily focused on the STN without specifically 
targeting the SNr. However, for patient inclusion into this study, 
we identified from the available post-operative images whether 
the lowermost contact was located at least −5 mm below the mid-
commissural point (MCP) in the rostro-caudal direction. This 
resembled the standards of our randomized controlled clinical 
trial on STN + SNr stimulation owing to the natural variability of 
electrode depth which may reach below the STN toward SNr or 
STN–SNr border zone (clinicaltrials.gov NCT02588144).
To avoid influence of the stun effect, we included only patients 
at least 3 months from STN-DBS implantation. Exclusion criteria 
were Mini Mental Status <22, Beck’s Depression Inventory >13, 
and other neurological or neuromuscular disease except PD. The 
local Ethics committee of the University of Tuebingen approved 
the study and all subjects provided written consent to participate 
in the study.
We excluded one patient because of technical problems with 
the recording hardware and one patient because he was unable 
to walk during the recording session. We observed FOG in 15 
out of 19 PD patients, confirming these PD patients as “definitive 
freezers” (24). FOG was triggered by 360° narrow turns in both 
directions in the “Off ” state before the measurement. This task 
can trigger FOG most effectively (24). We assured that stimula-
tion of the STN was effective with clinical improvement of at 
least 30% measured as Unified Parkinson’s Disease Rating Scale 
part 3 (UPDRS III) difference between Off stimulation and STN 
stimulation. Thus, we excluded 3 out of 15 PD patients.
We considered the remaining 12 PD freezers for further analy-
ses [PD1–PD12, 11 males, age: 63.7 ± 10.4 years (mean ± SD)]. 
The disease duration was 15.1 ± 3.2 years with implantation of 
the DBS 34.7 ± 29.0 months ago. The daily levodopa equivalent 
dose was on average 483 ± 327 mg. The score on the NFOG-Q 
was 9.4 ±  8.4 points. Pre-operatively, patient records pointed 
Table 1 | Stimulation parameters.
sTn snr
Voltage (V) 
(left/right)
contacts (left/right) Frequency 
(hz)
Pulse width (μs) 
(left/right)
Voltage (V) 
(left/right)
contacts (left/right) Frequency 
(hz)
Pulse width (μs) 
(left/right)
PD01 5.3/3.0 2–3+/10–11+ 125 60/60 3.5/3.5 0–1+/8–9+ 125 60/60
PD02 2.8/3.5 2–3+/10–11+ 130 60/60 2.5/1.9 0–1+/8–9+ 130 60/60
PD03 5.5/3.5 2–3+/10–11+ 130 60/60 2.9/2.9 0–1+/8–9+ 130 60/60
PD04 4.0/4.5 2–3+/10–11+ 130 60/60 2.7/2.7 0–1+/8–9+ 130 60/60
PD05 2.1/2.1 2–3+/10–11+ 125 60/60 1.6/1.6 0–1+/8–9+ 125 60/60
PD06 3.2/2.0 2–3+/10–11+ 130 60/60 2.2/2.2 0–1+/8–9+ 130 60/60
PD07 5.4/5.1 2–3+/10–11+ 130 90/90 1.3/1.3 0–1+/8–9+ 130 90/90
PD08 4.9/3.5 1-C+/9-C+ 130 90/60 2.5/2.5 0-C+/8-C+ 130 90/60
PD09 3.5/2.4 2-C+/10-C+ 125 60/60 1.6/1.6 0-C+/8-C+ 125 60/60
PD10 1.8/1.7 2-C+/10-C+ 125 90/90 1.0/1.0 0-C+/8-C+ 125 90/90
PD11 3.6/1.9 2–3+/10–11+ 130 60/60 0.3/0.3 0–C+/8-C+ 130 60/60
PD12 3.8/2.4 2–3+/10–11+ 125 60/60 0.8/0.8 0-C+/8-C+ 125 60/60
STN, subthalamic nucleus deep brain stimulation; SNr, substantia nigra deep brain stimulation.
Remark: after exclusion of PD11, only the gait asymmetry between SNr and Off stimulation did not reach significance anymore.
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to 10 out of 12 with FOG. Electrode coordinates of the caudal 
contact relative to the MCP were left SNr −10.2 ± 0.4, −3.7 ± 0.5, 
−6.5 ± 0.4; right SNr 10.4 ± 0.4, −4.0 ± 0.4, −6.3 ± 0.4 (x, y, z; x, 
medio-lateral; y, anterio-posterior; z, rostro-caudal).
experimental setup and Paradigm
Combined STN  +  SNr stimulation is under consideration to 
alleviate FOG (20). Whereas in current clinical trials impulses 
of STN and SNr are delivered concomitantly, we aimed to gain 
differentiated pathophysiological insight of either STN or SNr 
stimulation as single target stimulation on locomotor integra-
tion in this study. To this end, we contrasted the effects of either 
stimulation condition alone (i.e., mono SNr as compared to mono 
STN). We measured all patients in three conditions: STN, SNr, 
and Off stimulation after overnight withdrawal of dopaminergic 
medication. As a result, all measurements were performed “Off 
medication.” We assigned the order of the conditions randomly. 
Experimenters and patients were not blinded to the stimulation 
condition. Each stimulation condition was active for at least 
20  min prior to the recordings in order to achieve sufficient 
efficacy of stimulation and in order to limit potential carry-over 
effects of the previous therapeutic condition in line with previous 
standards (20, 25). As recordings took place in medication off, 
we did not consider longer off periods for washout, which would 
have led to patient discomfort.
Subthalamic nucleus stimulation represented stimulation of 
the rostral contact(s), while we delivered SNr stimulation on the 
caudal contact(s) (Table 1). Pulse width and frequency of the 
SNr stimulation were similar to the individual STN stimulation. 
We did not adjust SNr to STN amplitudes, since stimulation of 
nigral contacts (i) generally has a lower threshold for capsular 
side effects and (ii) lower SNr amplitudes (as compared to STN 
amplitudes) were clinically effective in our previous work (20). 
In this sense, we designed the stimulation conditions close to 
current clinical reprogramming standards on subthalamic and 
nigral stimulation. Therefore, the voltage was increased in small 
steps of 0.1  V until a clinical improvement of gait compared 
to Off stimulation was observed. If a side effect occurred, the 
highest amplitude possible without the emergence of side effects 
was chosen (Table 1). On average, we stimulated the left STN 
with 3.8 ± 1.3 V and the right STN with 3.0 ± 1.1 V. The left SNr 
was on average stimulated with 1.9 ± 1.0 V and the right SNr 
with 1.9 ±  0.9  V. Information on the potential side effects of 
SNr stimulation were reported in detail elsewhere (20). In this 
study, we were limited in amplitude increases on nigral contacts 
only in one patient (PD11), who showed blurred vision around 
amplitudes of 0.5 V and, therefore, was treated with rather low 
amplitudes in the SNr of bilateral 0.3 V (Table 1). In each condi-
tion, subjects walked on a straight over ground walkway of 9 m 
for kinematic gait analysis. Patients walked for about 3 min in 
their self-selected, comfortable pace. In case the PD patients had 
difficulty walking 3 min, they were asked to walk as long as they 
could. Before the start of each 9-m walking trajectory, subjects 
stood still for a few seconds with the feet put together in front 
of the starting line. Walking was self-initiated by the subjects. 
Walking aid, such as a cane or walking frame was allowed when 
used in daily life. The walking aid was used by only two patients 
and consistently used in all therapeutic conditions to facilitate 
comparability. In each condition, we assessed the clinical motor 
state using the UPDRS section III. Clinical subscores were 
composed: segmental (sum of items 20–26 +  31, only upper 
and lower limbs) and the gait and posture subscores (sum of 
items 27–30).
recordings
During walking, participants wore small, lightweight body-fixed 
sensors attached to the left and right ankle (about 20 mm above 
the malleolus), and to the lumbar spine with a belt (Opal, APDM, 
Portland, OR, USA). Each sensor contained a tri-axial acceler-
ometer, tri-axial gyroscope, and a tri-axial magnetometer with X, 
Y, and Z axes pointing in subjects’ viewing direction downward, 
rightward, and forward, respectively. Data were sampled at 128 Hz 
and transferred to Matlab (Release R2015b, The Mathworks, Inc., 
Natick, MA, USA) for further offline analysis. Furthermore, the 
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participants were video-taped to exclude dyskinesias and FOG 
episodes from analysis.
spatial and Temporal gait Parameters
We obtained gait events from the recorded inertial signals based 
on earlier work showing a good agreement between APDM 
sensors and the GAITRite system as gold standard (26, 27). 
Moreover, Opal sensors of APDM are well established and widely 
used. Gait events were determined using the acceleration in the 
anterior–posterior direction and the gyroscope in the medial–
lateral direction expressing the angular velocity in the sagittal 
plane. Briefly, first we identified the midswing (MS) as peak value 
exceeding 50°/s in the sagittal plane of the gyroscope signal. If 
multiple peak values with a maximum distance of 750 ms were 
found, the highest peak was selected and the others were rejected. 
In the time interval 750 ms before and after MS, we identified 
toe-off (TO) and heel-strike (HS). TO was identified as mini-
mum anterior–posterior acceleration in the time interval before 
MS, and HS was identified in the time interval after MS as the 
minimum value of angular velocity in the sagittal plane before the 
maximum anterior–posterior acceleration. A stride was defined 
as the time span between two consecutive HS of the same leg. All 
gait cycles were checked for the order of occurrence. For the kth 
gait cycle of the left leg the gait events were correct when:
 HSL < TOR < MSR < HSR < TOL < MSL < HSL.
We discarded gait cycles from further analyses in case of incor-
rect order of the gait events or if a gait event could not be detected. 
To exclude acceleration and deceleration during walking, the first 
and last two steps of each 9 m walkway were rejected. A minimal 
of 40 gait cycles (for a particular leg) remained for each partici-
pant in each condition for further analyses.
Using the gait events, we computed temporal and spatial gait 
outcome measures for each condition. We used as temporal meas-
ures the mean step time (in seconds, time between HS of one leg and 
HS of the other leg) and the variability of the step time. As spatial 
measures, we computed the stride length [as percentage of the leg 
length (% ll)] and the variability of stride length. Spatiotemporal 
consisted of the peak shank angular velocity (degree/seconds; 
sagittal maximum angular velocity during the swing phase) and 
the variability of peak shank angular velocity. The variability meas-
ures were calculated as the coefficient of variation (CV, 100%*SD 
normalized by the mean). We report the measures grouped by 
the more severely affected leg and less severely affected leg by PD 
(referred to as disease “dominant leg” resp. “non-dominant leg” in 
the following). As most objective marker, the dominant leg was 
determined as the leg yielding lower peak angular velocity during 
the swing phase in the Off condition as compared to the other leg.
Freezers have impaired bilateral coordination (28). Therefore, 
we observe the swing time asymmetry (STA) of the swing time 
defined in Ref. (29).
 STA = ( )ln lh ,  
where l is the swing time of the leg with the shorter swing time 
and h is the swing time of the leg with the greater swing time. STA 
closer to 0 represents a lower grade of asymmetry.
anatomical Position of snr contact
We determined the electrode position with respect to MCP 
of the bilateral lower contacts using co-registration of the 
pre-operative and post-operative MRI with Optivise software 
(Medtronic, Minneapolis, MN, USA). As previous animal work 
points to the relevance of laterality within the SNr regarding the 
modulation of locomotor integration (22), we aim to further 
explore the role of electrode positioning. Therefore, we corre-
lated the medio-lateral coordinate of the electrode (coordinate 
in x direction) with the spatial and temporal parameters of the 
dominant leg and STA.
statistical analyses
All statistical analyses were performed with exploratory intent. 
We report descriptive statistics as mean  ±  SD, unless stated 
otherwise. We tested for normal distribution of the data using 
the Kolmogorov–Smirnov test (p <  0.05). Based on this test, 
conditions were compared using a repeated measure ANOVA 
or Friedman test. In case of a significant ANOVA or Friedman 
test, post hoc tests were performed comparing Off with STN and 
Off with SNr stimulation, respectively, using a paired t-test or 
Wilcoxon test. All statistical analyses were performed with IBM 
SPSS statistics, version 22.0 (IBM Deutschland GmbH, Ehningen, 
Germany). Since one patient (PD11) could only be treated with 
reduced SNr amplitudes of 0.3 V owing to side effects in terms of 
blurred vision at higher amplitudes, we reanalyzed findings from 
SNr stimulation after exclusion of PD11.
resUlTs
clinical Outcome
Total UPDRSIII score significantly differed between condi-
tions (χ2 = 22.167, p < 0.001, Friedman test). STN stimulation 
improved the total UPDRSIII score with 38 ± 13% (percentage 
improvement of STN stimulation compared to “Off ” stimulation, 
normalized by the score in Off stimulation, STN–Off U = −3.059, 
p  =  0.002) and SNr stimulation with 18  ±  16% (SNr–Off 
U = −2.671, p = 0.008, Wilcoxon Test, Figure 1). The segmental 
subscore (χ2 = 22.167, p < 0.001) and the gait and posture sub-
score (χ2 = 15.235, p < 0.001) were changed by stimulation. STN 
stimulation improved the segmental subscore by 41 ± 13% and 
SNr stimulation by 19 ± 17% (STN–Off U = −3.061, p = 0.002; 
SNr–Off U = −2.515, p = 0.012). STN stimulation improved the 
gait and posture subscore by 27 ± 14% and SNr stimulation by 
18 ± 20% (STN–Off U = −2.980, p = 0.003; SNr–Off U = −2.280, 
p = 0.023) (Figure 1). All findings of SNr–Off stimulation on the 
UPDRSIII score and UPDRS III subscores remained after exclu-
sion of PD11 (all p < 0.05).
spatial and Temporal gait Parameters
Spatial parameters were only influenced by STN stimulation: we 
observed a stride length increment and stride length variability 
reduction compared to Off stimulation for the dominant leg 
(Table 2). SNr stimulation did not change the spatial parameters 
compared to Off stimulation. The variability of the step time 
was decreased by STN stimulation for both the dominant and 
non-dominant leg (Table 2). The step time and both average and 
FigUre 1 | Score of the total UPDRS III (left), segmental score (sum of items 
20–26 + 31, only upper and lower limbs), and gait and posture subscore 
(sum of items 27–30) during subthalamic nucleus (STN), substantia nigra 
pars reticulate (SNr), and Off stimulation. Significant differences (p < 0.05) are 
denoted by horizontal square brackets. Both STN and SNr stimulations could 
significantly improve the segmental and gait and posture subscore.
Table 2 | Dominant/non-dominant leg: spatial and temporal gait parameters.
gait parameter grand average (mean ± sD) p-Value p-Value
sTn snr Off sTn–Off snr–Off
D nD D nD D nD D nD D nD
Mean
Stride length (% ll) 66.1 ± 25.5 74.5 ± 21.7 54.8 ± 27.2 65.2 ± 26.8 53.1 ± 28.5 63.4 ± 27.8 0.01 n.s. 0.27 n.s.
PAV (deg/s) 226.3 ± 83.4 260.7 ± 77.4 202.2 ± 87.2 238.0 ± 76.6 195.6 ± 91.8 237.2 ± 77.0 n.s. n.s. n.s. n.s.
Step time (s) 0.62 ± 0.12 0.61 ± 0.11 0.59 ± 0.10 0.58 ± 0.11 0.60 ± 0.10 0.57 ± 0.08 n.s. n.s. n.s. n.s.
cV
Stride length 0.14 ± 0.12 0.13 ± 0.09 0.20 ± 0.20 0.17 ± 0.13 0.22 ± 0.16 0.16 ± 0.12 0.01 n.s. 0.08 n.s.
PAV 0.12 ± 0.09 0.10 ± 0.05 0.14 ± 0.09 0.13 ± 0.07 0.16 ± 0.10 0.12 ± 0.04 n.s. 0.09 n.s. 0.94
Step time 0.08 ± 0.04 0.08 ± 0.04 0.09 ± 0.05 0.10 ± 0.08 0.11 ± 0.08 0.10 ± 0.05 0.02 0.03 0.43 0.99
PAV, peak shank angular velocity; STN, subthalamic nucleus deep brain stimulation; SNr, substantia nigra deep brain stimulation; ll, leg length; D, dominant; ND, non-dominant; CV, 
coefficient of variation.
p-Values are computed with Friedman test and if significant, with Wilcoxon signed rank test.
Bold font was decided on p < 0.05.
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variability of the peak shank angular velocity were not influenced 
by both STN and SNr stimulations.
Swing time asymmetry was improved by both STN and SNr 
stimulation.  SNr stimulation also improved swing time asym-
metry compared to Off stimulation (Figure 2) at p < 0.05 (after 
exclusion of PD11 two-tailed p = 0.062).
anatomical Position of snr contact
We found a negative correlation between the alteration of 
peak angular velocity variability of the dominant leg by SNr 
stimulation and the laterality of the electrodes caudal contact 
(r = −0.594, p = 0.042, Figure 3). This indicates that patients with 
a more medial electrode position show a more regular gait pat-
tern induced by SNr stimulation. This correlation was still present 
after exclusion of PD11 (r = −0.651, p = 0.030). No correlation 
was found between electrode laterality and other gait parameters.
DiscUssiOn
Here, we found that STN stimulation improved both spatial 
and temporal characteristics of gait with a stride length incre-
ment, reduction of both stride length and step time variability, 
and increased swing time symmetry. Furthermore, mono SNr 
stimulation did not modulate spatial measures, but may affect the 
modulation of temporal gait integration by increasing the swing 
time symmetry. In addition, we found that patients with a more 
medial electrode position of the caudal contact associated with 
an improvement of the gait patterns regularity induced by mono 
SNr stimulation.
In line with our hypotheses, SNr stimulation can modulate the 
temporal characteristics of the gait cycle by reducing the STA. 
From animal experiments, we know that the MLR and the reticu-
lospinal tract are involved in the temporal modulation of the gait 
pattern. One of the target areas of the SNr is the MLR, which is 
considered the main locomotor center with a GABAergic connec-
tion between the SNr and the ponto-mesencephalic tegmentum 
(21). Our results suggest that SNr stimulation regulates temporal 
gait integration, presumably by modulating MLR, which has a 
predominant role in temporal adaptation. The PPN, as part of the 
MLR, can modify the cadence but not step length, as is suggested 
with PPN stimulation in PD patients (30). Furthermore, an MRI 
study revealed that increasing the gait speed during imaginary 
walking activates the MLR region (31). An earlier experimental 
clinical study on PD patients showed that SNr stimulation could 
improve the braking mechanism during gait initiation, but not the 
spatial parameters of gait (32). This decreased vertical accelera-
tion, as well as an increased gait asymmetry, is characteristic for 
axial motor impairment (33). The consistence of these kinematic 
findings with results from PPN stimulation may support the view 
that nigral stimulation might entrain pedunculopontine locomo-
tor integration (30, 31, 34).
Our results support the hypothesis that mono SNr stimula-
tion may support regulation of temporal gait characteristics. 
Furthermore, patients with a more medial location of the active 
SNr contact acquire a more regularized gait pattern with SNr 
stimulation. This correlation aligns with previous findings of 
FigUre 3 | Medio-lateral location of electrode of the most caudal contact is 
associated with the improvement of peak angular velocity variability by 
substantia nigra pars reticulate (SNr) stimulation. Both electrode position  
and CV of PAV are obtained from the dominant side. A more medial electrode 
position is associated with more regular gait induced by SNr stimulation 
(r = −0.594; p = 0.042). Abbreviations: CV, coefficient of variation; PAV,  
peak shank angular velocity.
FigUre 2 | Boxplot representing median values, 25–75% range (box) and 
min–max range (bars) of swing time asymmetry. Differences were computed 
with the Wilcoxon signed rank test and are denoted by horizontal square 
brackets. Abbreviations: STN, subthalamic nucleus deep brain stimulation; 
SNr, substantia nigra deep brain stimulation; ll, leg length; CV, coefficient of 
variation.
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animal experiments showing that stimulation of the medial SNr 
could modulate the temporal integration of gait, as opposed to the 
lateral part of the SNr (21, 22).
In daily life, FOG is still an unmet therapeutic need. As repro-
gramming strategy, we suggested combined STN + SNr stimula-
tion. However, the mechanism on how combined STN +  SNr 
stimulation might reduce FOG remains unknown. We did not 
consider the combined STN + SNr stimulation in this study for 
two major reasons. First, we aimed to achieve distinct effects on 
locomotor variables from potentially separate STN or SNr contri-
butions to gait integration since our primary interest was to obtain 
differentiated pathophysiological insight on the role of a distinct 
neuroanatomic target in locomotor integration. Furthermore, 
we were limited in the number of experimental conditions that 
patients under medication-off conditions could tolerate and, 
therefore, decided not to include a fourth condition on STN + SNr. 
We set the washout period between the conditions to 20 min in 
order to limit potential carry-over effects. Nevertheless, we can-
not fully exclude carry-over effects, although a period of 20 min 
is considered sufficient in the advanced disease stage (25). In this 
sense, we excluded three patients showing no clinical difference 
between Off stimulation and STN stimulation, either owing to 
incomplete washout of STN-DBS or stimulation effect.
Another methodological consideration in this study refers to 
our choice to use different stimulation intensities of mono STN 
and mono SNr stimulation. We decided in this way, since we 
wished to use stimulation intensities that closely adhere to current 
reprogramming standards from previous reports and randomized 
clinical trials, including the ongoing multicenter trial (ClinTrials.
gov: NCT02588) (20). We cannot fully exclude that stimulation of 
a dorsolateral STN contact would potentially affect adjacent struc-
tures owing to potential current spreading to adjacent structures, 
in particular when higher stimulation amplitudes are applied on 
the level of STN. Moreover, stimulation of the STN might not be 
limited to changing local STN activity, but might modulate adjacent 
structures through connectivity. The same applies for stimulation 
of the SNr although stimulated with lower amplitudes. On the 
other hand, the stimulation intensity of mono SNr stimulation was 
lower than that of mono STN stimulation, which could potentially 
account for a lower effect of SNr stimulation on clinical outcome 
measures. Nevertheless, higher stimulation intensities of the most 
caudal contact would have led to capsular side effects, in particular 
in more laterally localized electrodes and would have largely pre-
vented adjustment of stimulation intensities of subthalamic and 
nigral contacts. Finally, the applied SNr stimulation intensities 
were similar to effective parameters reported in previous work 
(20). Only in one patient (PD11), we were limited in increasing 
the nigral stimulation amplitudes owing to side effects in terms of 
blurred vision and therefore used the highest tolerable amplitudes 
at 0.3 V bilaterally. As this might potentially be subthreshold for 
inducing therapeutic effects from nigral neuromodulation, we 
reevaluated our statistical findings after exclusion of PD11. This 
led to largely consistent findings.
The findings from this study provide closer insight into the 
mechanisms of STN and SNr stimulations. We suggest as major 
finding from this study that STN stimulation modulates both 
spatial and temporal measures. Instead, nigral stimulation did 
not modulate spatial measures, but may affect the modulation of 
temporal gait integration. This could be mediated through MLR 
modulation when our findings are interpreted in the context of 
established knowledge about temporal integration pathways. 
Furthermore, patients with a more medial position of the caudal 
contact of the electrode show a more regular gait pattern induced 
by mono SNr stimulation. The findings presented here help to 
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decipher the enigmatic pathophysiological networks involved in 
gait in PD patients with FOG and encourage further studies on 
locomotor network modulation on the level of STN and SNr.
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